Washington, DC – President Joe Biden announced he is nominating Dr. Robert Califf to become the new commissioner of the Food and Drug Administration (FDA). Dr. Califf is a consummate professional dedicated to keeping Americans healthy and safe. His commitment, expertise, and thoughtful approach are why he was easily confirmed in the Senate for this post during the Obama Administration in 2016, and he should be confirmed again.

“Dr. Califf has done the job and knows what it takes to be successful. He is the right person at the right time to lead the FDA as our nation navigates the COVID-19 pandemic while still addressing additional urgent medical issues, including Alzheimer’s disease,” said George Vradenburg, chair and co-founder of UsAgainstAlzheimers. “As the leader of a patient-centered organization, I particularly value Dr. Califf’s patient-centered approach to research and advocacy, which will be key as we work together to end Alzheimer’s.”

UsAgainstAlzheimer’s also commends the leadership of Dr. Janet Woodcock, who has been serving as acting commissioner.

“I am extremely grateful to Dr. Woodcock, whose steady hand has helped guide us through one of the worst public health crises in American History,” Vradenburg said. “She is a respected and innovative leader who always puts patients first. Our country has benefitted tremendously from her decades of public service.”

A commitment to innovation and scientific-driven solutions is key in the fight to end Alzheimer’s, qualities Dr. Califf has exhibited throughout his career. UsAgainstAlzheimer’s calls on the United States Senate to confirm Dr. Califf expeditiously.

# # #

About UsAgainstAlzheimer’s

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. We take on the toughest problems; bring all of “Us” together to break down barriers; advocate for research that will speed treatments to market; and drive changes that matter most to people living with the disease. We will not rest until brain-span equals lifespan - for everyone.